Cision Ab Tikomed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ A new study with TikoMed s platform lead clinical drug candidate ILB®, provides positive safety and tolerability results and the first clinical.

Vastra gotalands lanAnders kristenssonAnn loganLennart perssonDepartment of clinical neuroscienceUniversity of warwickSahlgrenska university hospital in gothenburgUniversity of gothenburgInstitute of neuroscienceClinical neuroscienceProfessor ann loganSahlgrenska university hospitalAmyotrophic lateralCision ab tikomed